UCI study identifies ophthalmic acid as a neurotransmitter like dopamine, reversing Parkinson's mouse model movement impairments and potentially advancing treatment options.

A study from the University of California, Irvine, has identified ophthalmic acid as a neurotransmitter akin to dopamine, potentially offering new treatment avenues for Parkinson's and other movement disorders. The research demonstrated that ophthalmic acid activates calcium-sensing receptors in the brain, reversing movement impairments in Parkinson's mouse models for over 20 hours. This challenges the long-held belief that dopamine solely regulates motor function.

October 04, 2024
5 Articles